Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Uncontrolled Single Centre Study for the Evaluation of the Performance Characteristics (Efficacy and Safety) of the Dermal Filler MMG-23-04-2019 (Hyaluronic Acid 2,0%) for Female Intimate Area Hydration and Atrophy of the Vagina.

NCT04659668 is registered in ClinicalTrials.gov with Mesoestetic Pharma Group S.L. as lead sponsor.

NCT NCT04659668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04659668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Uncontrolled Single Centre Study for the Evaluation of the Performance Characteristics (Efficacy and Safety) of the Dermal Filler MMG-23-04-2019 (Hyaluronic Acid 2,0%) for Female Intimate Area Hydration and Atrophy of the Vagina.
Lead sponsor
Mesoestetic Pharma Group S.L.
Phase
Not applicable
Overall status
Completed
Start date
November 11, 2019
Completion date
August 17, 2020
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyspareunia, urinary incontinence, vaginal atrophy, vulvovaginal signs and symptoms